Inventor
BLERY MATHIEU
FR14 patents
⚠️ This page may combine multiple inventors who share the name “BLERY MATHIEU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNATE PHARMA
11 patentsUS10329348B2Jun 25, 2019
Treatment of cancers using anti-NKG2A agents
INNATE PHARMA16 citations92
US10711063B2Jul 14, 2020
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA8 citations83
US10676523B2Jun 9, 2020
Treatment regimens using anti-NKG2A antibodies
INNATE PHARMA7 citations80
US11572410B2Feb 7, 2023
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA3 citations72
US11225519B2Jan 18, 2022
Treatment of cancers using anti-NKG2A agents
INNATE PHARMA3 citations71
US10870700B2Dec 22, 2020
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA6 citations69
US10344087B2Jul 9, 2019
Treatment of peripheral T cell lymphoma
INNATE PHARMA3 citations69
US12365731B2Jul 22, 2025
NKp46 binding agents
INNATE PHARMA0 citations62
US11377492B2Jul 5, 2022
NKp46 binding agents
INNATE PHARMA1 citations62
US12037392B2Jul 16, 2024
Treatment regimens using anti-NKG2A antibodies
INNATE PHARMA0 citations59
US11999784B2Jun 4, 2024
Treatment of peripheral T cell lymphoma
INNATE PHARMA0 citations58